MTOR and neoplasm: In these prior studies, we demonstrated that pemetrexed and sorafenib interacted to kill tumor cells through endoplasmic reticulum stress signaling, inactivation of the PI3K/mTor pathway, and the induction of a toxic form of autophagic flux [6, 19].